<code id='D26D76DD75'></code><style id='D26D76DD75'></style>
    • <acronym id='D26D76DD75'></acronym>
      <center id='D26D76DD75'><center id='D26D76DD75'><tfoot id='D26D76DD75'></tfoot></center><abbr id='D26D76DD75'><dir id='D26D76DD75'><tfoot id='D26D76DD75'></tfoot><noframes id='D26D76DD75'>

    • <optgroup id='D26D76DD75'><strike id='D26D76DD75'><sup id='D26D76DD75'></sup></strike><code id='D26D76DD75'></code></optgroup>
        1. <b id='D26D76DD75'><label id='D26D76DD75'><select id='D26D76DD75'><dt id='D26D76DD75'><span id='D26D76DD75'></span></dt></select></label></b><u id='D26D76DD75'></u>
          <i id='D26D76DD75'><strike id='D26D76DD75'><tt id='D26D76DD75'><pre id='D26D76DD75'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:3975
          Exterior photo of UnitedHealth Group building
          Courtesy UnitedHealth Group

          UnitedHealth Group has about 90,000 employed or affiliated doctors, approximately 10% of all physicians in the U.S.

          The number — disclosed Wednesday at the company’s investor day by Amar Desai, the CEO of UnitedHealth’s Optum Health division — means the company acquired or hired 20,000 doctors in the past year alone.

          advertisement

          The rapid growth of UnitedHealth’s physician base underscores how the company, which already is the country’s largest private health insurer, is looking to control more of the health care delivery system, and how this growth is going unchecked by antitrust agencies.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Albert Bourla of Pfizer: worst biopharma CEO of 2023
          Albert Bourla of Pfizer: worst biopharma CEO of 2023

          HyacinthEmpinado/STATPfizeristhisyear’santi-EliLilly.IfDavidRicksisthebestbiopharmaCEOof2023,thenPfi

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          David Ricks of Eli Lilly: best biopharma CEO of 2023

          HyacinthEmpinado/STATIt’sthattimeoftheyearagainwhenIrecognizetheBestBiopharmaCEOoftheyear.Thisyear’s